BiotechTube
Home/Lannett/Michael Block
MB

Michael Block

Business Development

Lannett

Therapeutic Areas

CardiovascularCNSAnalgesicsImmunosuppression

Lannett Pipeline

DrugIndicationPhase
Mycophenolate Mofetil for Oral SuspensionImmunosuppression (e.g., organ transplant rejection)ANDA Approved

Leadership Team at Lannett

TC
Tim Crew
Chief Executive Officer
View full Lannett profile